Explore the evolving role of flow cytometry in supporting cellular therapies, from comprehensive immune cell characterization to accurate cell enumeration.

This presentation examines how flow cytometry supports the development and clinical evaluation of cell therapies, including CAR T-cell programs, through advanced immunophenotyping, quantitative cell measurements, and standardized analytical approaches. Learn best practices for measuring rare cell populations, generating reliable absolute cell counts, and applying high-parameter flow cytometry to monitor therapeutic responses throughout clinical development.

Key topics include:

• The role of flow cytometry in monitoring CAR T-cell therapies and other cellular therapies
• Best practices for quantitative flow cytometry, rare event detection, and absolute cell counting
• The advantages of high-parameter and spectral flow cytometry for immune cell characterization
• The NIST Flow Cytometry Standards Consortium and its efforts to advance standardization and measurement confidence across the industry

As cellular therapies continue to transform medicine, generating accurate, reproducible analytical data is essential. Discover how advanced flow cytometry strategies and emerging industry standards are helping improve characterization, monitoring, and clinical decision-making for next-generation cell therapies.